Evidence map›Paper›PMID 24944690›Full record

ArticleOncology letters2014

Clinical outcomes and prediction of survival following percutaneous biliary drainage for malignant obstructive jaundice.

Guang Yuan Zhang, Wen Tao Li, Wei Jun Peng, Guo Dong Li, Xin Hong He, Li Chao Xu

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03054987 (Randomized Trial Comparing Endoscopic Ultrasound-guided Biliary Drainage), which is not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03054987 nacompletednot on this mapstarted 2016, after this paper: background citation

Randomized Trial Comparing Endoscopic Ultrasound-guided Biliary Drainage (EUS-BD) and Endoscopic Retrograde Cholangiopancreatography (ERCP) for Malignant Distal Biliary Obstruction

TypeinterventionalSponsorAdventHealthRan2016 to 2018Enrolled67ConditionsPancreatic Cancer, Pancreatic Neoplasms, Pancreatic AdenocarcinomaArmsEUS-BD, ERCP
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Observational
  6. Percutaneous Transhepatic Biliary Intervention for The Management of Malignant Hilar Biliary Obstruction.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Palliative Care in Cholangiocarcinoma.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Guang Yuan ZhangDepartment of Radiology, Shanghai Cancer Center, Fudan University, Shanghai 200032, P.R. China.
Wen Tao LiDepartment of Radiology, Shanghai Cancer Center, Fudan University, Shanghai 200032, P.R. China.
Wei Jun PengDepartment of Radiology, Shanghai Cancer Center, Fudan University, Shanghai 200032, P.R. China.
Guo Dong LiDepartment of Radiology, Shanghai Cancer Center, Fudan University, Shanghai 200032, P.R. China.
Xin Hong HeDepartment of Radiology, Shanghai Cancer Center, Fudan University, Shanghai 200032, P.R. China.
Li Chao XuDepartment of Radiology, Shanghai Cancer Center, Fudan University, Shanghai 200032, P.R. China.
Fudan University Shanghai Cancer Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to investigate the clinical outcomes of percutaneous transhepatic biliary drainage in patients with obstructive jaundice and identify potential predictors of patient survival. Clinical data from 102 patients (66 males and 36 females; median age, 63.50 years; range, 29-84 years) with a mean (± standard deviation) pre-drainage serum bilirubin level of 285.4 (±136.7 μmol/l), were retrospectively studied. Technical and clinical success, complications and survival time were recorded and their relationship with clinical factors, including age, obstruction level, liver metastases, serum bilirubin level and subsequent treatments following drainage, were analyzed by Fisher's exact test. Patient survival rate and other predictors were analyzed by Kaplan-Meier survival curves and Cox's proportional hazard model. The technical and clinical success rates were 100 and 76.5%, respectively. The presence of liver metastases was associated with reduced successful drainage. The overall complication rate was 7.8% and the overall median survival time was 185 days [95% confidence interval (CI), 159-211 days]. A log-rank test showed that age (χ

Indexed as

malignant obstructive jaundicepercutaneous transhepatic biliary drainagesurvival

Identifiers

PMID24944690
PMCPMC3961454
OpenAlexW2046192575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.